April 17, 2025

Climate Identified as Key Virus Driver

Researchers found Oropouche virus to be underreported during a large-scale study across Latin America, with climate emerging as the primary driver of transmission risk.

Conexiant

April 07, 2025

Invasive Strep A Infections Double in the U.S.

Invasive group A streptococcal infections increased from 3.6 to 8.2 per 100,000 persons across 10 U.S. states over a 10-year period.

Conexiant

April 04, 2025

Gram-Negative Infection: 7 vs 14 Days of Antibiotics

Mortality occurred in 12.8% of the patients in the 7-day group compared with 13.7% of those in the 14-day group.

Conexiant

April 03, 2025

New Option for IgA Nephropathy Management

The FDA has granted accelerated approval to Vanrafia (atrasentan) for reducing proteinuria in adults with primary immunoglobulin A nephropathy who are at risk of rapid disease progression.

Conexiant

April 02, 2025

HPV Testing Guidelines Updated for Head and Neck Carcinomas

New evidence expands recommendations for sinonasal squamous cell carcinoma and standardizes p16 immunohistochemistry interpretation.

Conexiant

April 01, 2025

Cracking the Bacterial Vaginosis Resistance Code

Investigators have identified distinct Gardnerella species with varying antibiotic resistance patterns, potentially guiding more effective treatment for recurrent bacterial vaginosis.

Conexiant

March 25, 2025

Microplastics: Chewing Gum May Release Particles Into Saliva

"Surprisingly, both synthetic and natural gums had similar amounts of microplastics released when we chewed them."

Conexiant

March 20, 2025

Prenatal Exposure to PFAS in Contaminated Water

Results suggest associations between predicted prenatal maternal PFAS serum concentrations and some childhood cancers

Conexiant

February 12, 2025

FDA & EMA: Submitted Trial Data Discrepancies

Sample size discrepancies were identified in 13 trials (65%), with 8 differing by more than 10%.

Conexiant